Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Orlistat × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Obesity 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 61 Paclitaxel 42 Radiotherapy 39 Cisplatin 37 Pemetrexed 36 Bevacizumab 36 Docetaxel 25 Gemcitabine 24 Erlotinib Hydrochloride 20 Gefitinib 17 pembrolizumab 13 Taxes 10 Cetuximab 10 Magnetic Resonance Spectroscopy 8 Vinorelbine 7 Nivolumab 7 Surgical Procedures, Operative 6 Radiotherapy, Conformal 6 Radiosurgery 6 Radiation 6 Platinum 6 Etoposide 6 capmatinib 5 Specimen Handling 5 Neoadjuvant Therapy 5 Mastectomy, Segmental 5 Cyclophosphamide 5 Biopsy 5 ceritinib 4 aflutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06818955 2025-02-12

OOTER

Tongji Hospital

Phase 2 Not yet recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡